Amprenavir

Brand name: Agenerase

D

Score D — Possible Hepatotoxin

Single case reports have appeared implicating this drug, but the evidence is limited.

Fewer than 3 cases have been reported in the literature. No characteristic signature has been identified, and the case reports may not have been very convincing.

Primary class Antimicrobial
Secondary class Antiviral: HIV
FDA approval 1999